FDA Inspection 972459 — Aino Co., Ltd. Of North China Pharma. Group

Aino Co., Ltd. Of North China Pharma. Group — FEI 3004090057

The FDA completed an inspection of Aino Co., Ltd. Of North China Pharma. Group on Apr 29, 2016 in Shijiazhuang, Hebei. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 29, 2016
Fiscal Year
2016
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Shijiazhuang, Hebei (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.